Lipella Pharmaceuticals Inc.
LIPO· Unspecified
LIPOLipella Pharmaceuticals Inc.
Filed May 12, 2023 · 10-Q · 42 days after period end · 0001753926-23-000649
| Metric | Q1 2023 | Q1 2022 |
|---|---|---|
| Revenue | $118.05K | $33.15K |
| Net Income | -$1.07M | -$737.95K |
| EPS Diluted | -$0.19 | -$0.19 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipella Pharmaceuticals Inc. · CIK 1347242 · Engraved from SEC EDGAR
ended Mar 31, 2023 · filed May 12, 2023 · 42 d after period end
